A Phase I Dose-escalation Trial to Assess Safety and Efficacy of Cellistem-OA in Patients With Knee Osteoarthritis (CLT-OA1)

Cobertura de los medios

• Nombre	A Phase I Dose-escalation Trial to Assess Safety and Efficacy of Cellistem-OA in Patients With Knee Osteoarthritis (CLT-OA1)
  Nombre/canal del medio de comunicación	Pharmacy Choice
  País/Territorio	Estados Unidos
  Fecha	1/02/19
  URL	www.pharmacychoice.com/news/article.cfm?Article_ID=2180361
  Personas	Francisco Espinoza